Kistler-Tiffany Companies’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $176K | Buy |
2,283
+5
| +0.2% | +$399 | 0.03% | 330 |
|
|
2023
Q1 | $189K | Sell |
2,278
-44
| -2% | -$3.64K | 0.04% | 286 |
|
|
2022
Q4 | $199K | Sell |
2,322
-1,454
| -39% | -$115K | 0.04% | 262 |
|
|
2022
Q3 | $233K | Buy |
3,776
+8
| +0.2% | +$504 | 0.05% | 192 |
|
|
2022
Q2 | $233K | Sell |
3,768
-2,698
| -42% | -$167K | 0.05% | 191 |
|
|
2022
Q1 | $384K | Buy |
6,466
+4,801
| +288% | +$307K | 0.07% | 159 |
|
|
2021
Q4 | $121K | Sell |
1,665
-243
| -13% | -$16.7K | 0.02% | 253 |
|
|
2021
Q3 | $133K | Sell |
1,908
-147
| -7% | -$10.3K | 0.03% | 232 |
|
|
2021
Q2 | $141K | Buy |
2,055
+477
| +30% | +$31.9K | 0.03% | 227 |
|
|
2021
Q1 | $102K | Buy |
1,578
+22
| +1% | +$1.42K | 0.03% | 245 |
|
|
2020
Q4 | $91K | Hold |
1,556
| – | – | 0.03% | 238 |
|
|
2020
Q3 | $98K | Hold |
1,556
| – | – | 0.03% | 213 |
|
|
2020
Q2 | $120K | Sell |
1,556
-473
| -23% | -$36.2K | 0.04% | 181 |
|
|
2020
Q1 | $132K | Hold |
2,029
| – | – | 0.05% | 169 |
|
|
2019
Q4 | $132K | Sell |
2,029
-2,437
| -55% | -$159K | 0.05% | 174 |
|
|
2019
Q3 | $283K | Sell |
4,466
-856
| -16% | -$56K | 0.11% | 119 |
|
|
2019
Q2 | $360K | Buy |
5,322
+601
| +13% | +$39.5K | 0.14% | 94 |
|
|
2019
Q1 | $307K | Sell |
4,721
-2,240
| -32% | -$149K | 0.13% | 106 |
|
|
2018
Q4 | $435K | Sell |
6,961
-1,066
| -13% | -$74.5K | 0.2% | 72 |
|
|
2018
Q3 | $620K | Buy |
8,027
+52
| +0.7% | +$3.93K | 0.26% | 68 |
|
|
2018
Q2 | $565K | Sell |
7,975
-1,068
| -12% | -$75.4K | 0.25% | 71 |
|
|
2018
Q1 | $682K | Sell |
9,043
-145
| -2% | -$11.5K | 0.28% | 66 |
|
|
2017
Q4 | $658K | Buy |
9,188
+706
| +8% | +$53.6K | 0.26% | 70 |
|
|
2017
Q3 | $687K | Sell |
8,482
-54
| -0.6% | -$4.13K | 0.29% | 60 |
|
|
2017
Q2 | $604K | Buy |
8,536
+513
| +6% | +$34.1K | 0.28% | 62 |
|
|
2017
Q1 | $545K | Buy |
8,023
+144
| +2% | +$10.1K | 0.26% | 63 |
|
|
2016
Q4 | $564K | Buy |
7,879
+2,629
| +50% | +$195K | 0.28% | 58 |
|
|
2016
Q3 | $415K | Buy |
5,250
+1,359
| +35% | +$110K | 0.2% | 78 |
|
|
2016
Q2 | $325K | Buy |
3,891
+324
| +9% | +$28.8K | 0.17% | 87 |
|
|
2016
Q1 | $328K | Buy |
3,567
+847
| +31% | +$76.4K | 0.18% | 83 |
|
|
2015
Q4 | $282K | Buy |
2,720
+643
| +31% | +$66.9K | 0.16% | 92 |
|
|
2015
Q3 | $211K | Buy |
2,077
+682
| +49% | +$75.7K | 0.13% | 116 |
|
|
2015
Q2 | $163K | Buy |
1,395
+112
| +9% | +$12.2K | 0.1% | 142 |
|
|
2015
Q1 | $126K | Buy |
1,283
+418
| +48% | +$42.4K | 0.08% | 152 |
|
|
2014
Q4 | $82K | Sell |
865
-449
| -34% | -$46.4K | 0.05% | 191 |
|
|
2014
Q3 | $140K | Hold |
1,314
| – | – | 0.09% | 139 |
|
|
2014
Q2 | $109K | Sell |
1,314
-346
| -21% | -$26.9K | 0.08% | 160 |
|
|
2014
Q1 | $118K | Buy |
1,660
+320
| +24% | +$25.1K | 0.09% | 145 |
|
|
2013
Q4 | $101K | Buy |
1,340
+200
| +18% | +$13.9K | 0.08% | 163 |
|
|
2013
Q3 | $72K | Buy |
1,140
+443
| +64% | +$26.5K | 0.06% | 188 |
|
|
2013
Q2 | $36K | Buy |
+697
| New | +$36.3K | 0.03% | 251 |
|
Other funds holding GILD
Kistler-Tiffany Companies's GILD Position: Q2 2023 in Review
Kistler-Tiffany Companies increased its Gilead Sciences (GILD) stake by 0.22% in Q2 2023, buying an estimated $399 and bringing the position to 2,283 shares worth $176K. The position accounts for 0.03% of the portfolio, ranked #330.
Kistler-Tiffany Companies first reported a position in GILD in Q2 2013 and has held it in 41 quarters since. The position peaked at $687K in Q3 2017. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.
- Kistler-Tiffany Companies held 2,283 shares of Gilead Sciences worth $176K as of Q2 2023.
- Kistler-Tiffany Companies bought 5 Gilead Sciences shares in Q2 2023, an estimated $399.
- Gilead Sciences made up 0.03% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #330 holding.
- Kistler-Tiffany Companies first reported a position in Gilead Sciences in Q2 2013 and has held it in 41 quarters since.
- Kistler-Tiffany Companies's Gilead Sciences position peaked at $687K in Q3 2017.
- 1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.
Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.